Select Page

US FDA has issued a series of guidance’s to assists the sponsor and applicant in the generic drug development.

The March month has around 02 new/revised guidance under GDUFA and ICH provisions. The links of the guidance’s are provided below for quick review and reference. 

1. Pre-Launch Activities Importation Requests (PLAIR)

2. ICH Q14: Analytical Procedure Development

Don`t copy text!